Literature DB >> 18811688

Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes.

V A Kinsler1, J Birley, D J Atherton.   

Abstract

BACKGROUND: The aetiology of congenital melanocytic naevi (CMNs) is unknown.
OBJECTIVES: To identify potential aetiological factors in families of children with CMNs, and to relate these to long-term outcome measures.
METHODS: Three hundred and forty-nine CMN families completed questionnaires about pregnancy and parental factors, and yearly questionnaires on the health of their child and details of the CMN. Seventy-nine control families completed one set of questionnaires, excluding CMN details.
RESULTS: The mean prospective follow-up of 301 CMN families was 9.2 years, median 8.9 years, total 2679 years. Forty per cent of patients had CMNs > 20 cm projected adult size (PAS) or multiple CMNs. Twenty per cent of patients had abnormal neurodevelopment and although this was positively associated with PAS it was seen across all size categories. The rate of malignant melanoma was 1.4%. This was strongly associated with PAS with all five cases in patients with CMNs > 60 cm PAS/multiple CMNs (rate in that group 14%). Twenty-five per cent of CMN patients had a positive family history of a CMN in a second-degree relative (FHCMN). This group had a significantly different gender ratio, suggesting a different underlying mutation. Maternal FHCMN was negatively associated with PAS and satellites at birth, and maternal freckling was negatively associated with PAS. Other factors found to be significantly increased in CMN families compared with controls were maternal smoking and ill health during pregnancy. Maternal smoking was positively associated with PAS.
CONCLUSIONS: This study relies on data from families after they have had a child with a CMN, and therefore may be subject to recall bias. Despite this, it contributes significantly to the knowledge of epidemiology of CMNs, and provides some important clues to the genetic basis of the condition.

Entities:  

Mesh:

Year:  2008        PMID: 18811688     DOI: 10.1111/j.1365-2133.2008.08849.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

Review 1.  [New aspects of congenital melanocytic nevi].

Authors:  S Krengel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

2.  Topical therapy for regression and melanoma prevention of congenital giant nevi.

Authors:  Yeon Sook Choi; Tal H Erlich; Max von Franque; Inbal Rachmin; Jessica L Flesher; Erik B Schiferle; Yi Zhang; Marcello Pereira da Silva; Alva Jiang; Allison S Dobry; Mack Su; Sharon Germana; Sebastian Lacher; Orly Freund; Ezra Feder; Jose L Cortez; Suyeon Ryu; Tamar Babila Propp; Yedidyah Leo Samuels; Labib R Zakka; Marjan Azin; Christin E Burd; Norman E Sharpless; X Shirley Liu; Clifford Meyer; William Gerald Austen; Branko Bojovic; Curtis L Cetrulo; Martin C Mihm; Dave S Hoon; Shadmehr Demehri; Elena B Hawryluk; David E Fisher
Journal:  Cell       Date:  2022-05-12       Impact factor: 66.850

3.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

Review 4.  Biologically distinct subsets of nevi.

Authors:  Tova Rogers; Maria L Marino; Patricia Raciti; Manu Jain; Klaus J Busam; Michael A Marchetti; Ashfaq A Marghoob
Journal:  G Ital Dermatol Venereol       Date:  2016-04-27       Impact factor: 2.011

5.  Visual Impact of Large and Giant Congenital Naevi: Comparison of Surgical Scars with Naevi Before Surgery.

Authors:  Francesca Sampogna; Melinda González; Mirella Pascini-Garrigós; Neus Calbet-Llopart; Jennifer L Hay; Bruce S Bauer; Susana Puig; Josep Malvehy; Ashfaq A Marghoob; Cristina Carrera
Journal:  Acta Derm Venereol       Date:  2021-06-02       Impact factor: 3.875

6.  Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.

Authors:  Jeffrey S Pawlikowski; Claire Brock; Sheau-Chiann Chen; Lara Al-Olabi; Colin Nixon; Fiona McGregor; Simon Paine; Estelle Chanudet; Wendy Lambie; William M Holmes; James M Mullin; Ann Richmond; Hong Wu; Karen Blyth; Ayala King; Veronica A Kinsler; Peter D Adams
Journal:  J Invest Dermatol       Date:  2015-03-27       Impact factor: 8.551

Review 7.  The impact of pediatric skin disease on self-esteem.

Authors:  K L Vivar; L Kruse
Journal:  Int J Womens Dermatol       Date:  2017-12-12

8.  Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.

Authors:  Veronica A Kinsler; Anna C Thomas; Miho Ishida; Neil W Bulstrode; Sam Loughlin; Sandra Hing; Jane Chalker; Kathryn McKenzie; Sayeda Abu-Amero; Olga Slater; Estelle Chanudet; Rodger Palmer; Deborah Morrogh; Philip Stanier; Eugene Healy; Neil J Sebire; Gudrun E Moore
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551

Review 9.  Giant congenital melanocytic nevus.

Authors:  Ana Carolina Leite Viana; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

10.  Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development.

Authors:  Veronica A Kinsler; Sayeda Abu-Amero; Peter Budd; Ian J Jackson; Susan M Ring; Kate Northstone; David J Atherton; Neil W Bulstrode; Philip Stanier; Raoul C Hennekam; Neil J Sebire; Gudrun E Moore; Eugene Healy
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.